1)P. 13419, line 10, and pp. 13443, line 12 until p. 13444, line 17: The exploitation of the three-dimensional radiation transfer model MYSTIC is mentioned at the end of the first paragraph. While reading the entire manuscript, the reviewer was not able to find graphs for MYSTIC results, even though MYSTIC was described in some detail in section 4 of the manuscript. Thus, the reader is given th...

This article evaluates a striking similarity between two passages, one from the emperor Julian (‘the Apostate’), and the other from G. I. Gurdjieff (1865?-1949). These passages present the ‘sun’ as the source of ‘nous’ (Julian), or ‘higher centres’ (Gurdjieff). I suggest that these two faculties are effectively the same, as in both systems these faculties ground mystic experiences. In both syst...

Timothy Sullivan is Co-Founder, President & CEO of Mystic Pharmaceuticals. Over the past 37 years he has created novel technologies, products, and services and grown seven companies, three of which were acquired by major corporations. Mr. Sullivan is co-inventor of Mystic’s novel drug delivery technology platforms and responsible for defining both the technological and strategic direction of My...

The Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program was a global, longitudinal antimicrobial resistance surveillance network of more than 100 medical centers worldwide monitoring the susceptibility of meropenem and selected other broad-spectrum comparator agents. In 1999, and from 2000 through 2008, a total of 10 or 15 United States (USA) medical centers each forwar...